Skip to content

Social Cognition in Patients With Amyotrophic Lateral Sclerosis

Social Cognition in Patients With Amyotrophic Lateral Sclerosis

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04406675
Acronym
COSISLA
Enrollment
58
Registered
2020-05-28
Start date
2020-09-21
Completion date
2026-05-29
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Cognition

Brief summary

Amyotrophic Lateral Sclerosis, also known as Charcot disease, is a neurodegenerative disease evidenced by gradual paralysis of the muscles involved in voluntary motor function. The clinical hallmark of Amyotrophic Lateral Sclerosis is the combination of upper and lower motor neuron signs and symptoms. The most recent studies suggest that up to 50% of Amyotrophic Lateral Sclerosis patients demonstrate mild to moderate cognitive disturbance. Impaired social cognition, including a deficit in the recognition of facial emotions and the identification of vocal prosody, is recognized as a part of the cognitive phenotype of Amyotrophic Lateral Sclerosis, with crucial implications for patients' and caregivers' training. However, studies remain scarce and the data acquired must be supported. The evolution of these manifestations during the disease is still poorly understood. In this study the investigators aim to assess the social cognition capacities of patients with Amyotrophic Lateral Sclerosis compared to healthy matched control subjects.

Interventions

neuropsychological test

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patient Amyotrophic Lateral Sclerosis : * Education of at least 7 years * Native language: French * Patients Amyotrophic Lateral Sclerosis * Signature of informed consent to participate in the study * Accompanied patient Control subject : * People without any pathology * Education of at least 7 years * Native language: French * Signature of informed consent to participate in the study

Exclusion criteria

Patient Amyotrophic Lateral Sclerosis and control subject : * Simultaneous participation in another interventional protocol with experimental treatment * Inability to perform cognitive study tests * Pregnant, lactating or parturient women * Persons deprived of their liberty by administrative or judicial decision * Persons under psychiatric care under duress * Persons subject to legal protection measures * Persons out of state to express their consent * People not affiliated or not beneficiaries of a social security scheme * History likely to disturb cognition

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the social cognition capacitiesOne dayEvaluate the social cognition capacities of patients with Amyotrophic Lateral Sclerosis compared to control subjects using dynamic social cognition tests : Movie for the Assessment of Social Cognition. The maximum score is 48 points. The higher the score for correct answers, the better the performance.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026